Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Non-Current Deffered Revenue: 2020-2021

  • GeneDx Holdings' Non-Current Deffered Revenue was N/A to $295.0 million in Q2 2021 from the same period last year, while for Jun 2021 it was $295.0 million, marking a year-over-year change of. This contributed to the annual value of $132.0 million for FY2020, which is N/A change from last year.
  • As of Q2 2021, GeneDx Holdings' Non-Current Deffered Revenue stood at $295.0 million, which was down 0.64% from $297.0 million recorded in Q1 2021.
  • GeneDx Holdings' 5-year Non-Current Deffered Revenue high stood at $297.0 million for Q1 2021, and its period low was $15.5 million during Q3 2020.
  • Its 2-year average for Non-Current Deffered Revenue is $184.9 million, with a median of $213.5 million in 2020.